Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HLB Innovation, formerly known as U&I Corporation, is a South Korean medical technology company specializing in the development and manufacture of orthopedic implants and spinal fixation systems. Founded in 1993, the company has established a significant presence in the global medical device market with products such as pedicle screws, cages, and biodegradable bone fixation materials. A cornerstone of their innovation is the "Resomet" technology, a proprietary biodegradable magnesium alloy that allows implants to dissolve naturally in the body, eliminating the need for secondary removal surgeries. Following its acquisition by the HLB Group in 2022, the company has integrated into a larger bio-conglomerate, expanding its strategic focus while maintaining its leadership in orthopedic solutions. Their products are widely utilized in treating degenerative disc diseases, spinal deformities, and complex fractures across international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on U&i.